{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:54:08Z","timestamp":1779119648559,"version":"3.51.4"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Type 1 diabetes mellitus (T1DM) is caused by immune cell-mediated \u03b2-cell dysfunction. In recent decades, N6-methyladenosine (m6A) has attracted widespread attention in the scientific research field because it plays vital roles in the pathogenesis of immunity-related diseases, including autoimmune diseases. However, neither the m6A modification profile nor the potential role it plays in T1DM pathogenesis has been investigated to date.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>An m6A mRNA epitranscriptomic microarray analysis was performed to analyze m6A regulator expression patterns and m6A methylation patterns in immune cells of T1DM patients (n=6) and healthy individuals (n=6). A bioinformatics analysis was subsequently performed to explore the potential biological functions and signaling pathways underlying T1DM pathogenesis. Furthermore, mRNA expression and m6A methylation levels were subsequently verified by qRT\u2013PCR and methylated RNA immunoprecipitation\u2013qPCR (MeRIP\u2013qPCR), respectively, in the T1DM and healthy groups (n=6 per group).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the multiple m6A regulators, METTL3 and IGF2BP2 had significantly downregulated expression, and YTHDC1 and HNRNPA2B1 had significantly upregulated expression in the T1DM group relative to the healthy group. The microarray analysis revealed 4247 differentially methylated transcripts, including 932 hypermethylated and 3315 hypomethylated transcripts, and 4264 differentially expressed transcripts, including 1818 upregulated transcripts and 2446 downregulated transcripts in the T1DM group relative to the healthy group. An association analysis between methylation and gene expression demonstrated that the expression of 590 hypermethylated transcripts was upregulated, and that of 1890 hypomethylated transcripts was downregulated. Pearson correlation analysis showed significant correlations between the expression levels of differentially expressed m6A regulators and the methylation levels of differentially methylated transcripts and significant correlations between the expression levels of differentially expressed m6A regulators and that of differentially expressed transcripts. Moreover, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses demonstrated that differentially methylated transcripts were involved in pathways related to immunity, including some closely associated with T1DM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study presents m6A regulator expression patterns and m6A methylation patterns of immune cells in T1DM, showing that the m6A mark and m6A regulators are promising targets for T1DM diagnosis and treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.1030728","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T13:50:20Z","timestamp":1668520220000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["The m6A methylation profiles of immune cells in type 1 diabetes mellitus"],"prefix":"10.3389","volume":"13","author":[{"given":"Yimeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuoming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haipeng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuemin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiajie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3097","article-title":"Type 1 diabetes","volume":"9","author":"Burn","year":"2010","journal-title":"Nat Rev Drug Discovery"},{"key":"B3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cmet.2019.11.017","article-title":"New frontiers in the treatment of type 1 diabetes","volume":"31","author":"Warshauer","year":"2020","journal-title":"Cell Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.8","article-title":"Combination immunotherapies for type 1 diabetes mellitus","volume":"11","author":"Pozzilli","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.04.025","article-title":"Where, when, and how: Context-dependent functions of RNA methylation writers, readers, and erasers","volume":"74","author":"Shi","year":"2019","journal-title":"Mol Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau1646","article-title":"RNA Modifications modulate gene expression during development","volume":"361","author":"Frye","year":"2018","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2020.11.005","article-title":"Chromatin and transcriptional regulation by reversible RNA methylation","volume":"70","author":"Wei","year":"2021","journal-title":"Curr Opin Cell Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.755691","article-title":"The emerging role of m6A modification in regulating the immune system and autoimmune diseases","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5735279","DOI":"10.1155\/2020\/5735279","article-title":"Decreased ALKBH5, FTO, and YTHDF2 in peripheral blood are as risk factors for rheumatoid arthritis","volume":"2020","author":"Luo","year":"2020","journal-title":"BioMed Res Int"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.607585","article-title":"METTL3 promotes activation and inflammation of FLSs through the NF-\u03baB signaling pathway in rheumatoid arthritis","volume":"8","author":"Shi","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1298","DOI":"10.1002\/mgg3.1298","article-title":"The study of METTL14, ALKBH5, and YTHDF2 in peripheral blood mononuclear cells from systemic lupus erythematosus","volume":"8","author":"Luo","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"8193895","DOI":"10.1155\/2020\/8193895","article-title":"Decreased peripheral blood ALKBH5 correlates with markers of autoimmune response in systemic lupus erythematosus","volume":"2020","author":"Luo","year":"2020","journal-title":"Dis Markers"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2020.07.001","article-title":"A new model of spontaneous colitis in mice induced by deletion of an RNA m(6)A methyltransferase component METTL14 in T cells","volume":"10","author":"Lu","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"eabg0470","DOI":"10.1126\/sciadv.abg0470","article-title":"m6A demethylase ALKBH5 controls CD4(+) T cell pathogenicity and promotes autoimmunity","volume":"7","author":"Zhou","year":"2021","journal-title":"Sci Adv"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.11.026","article-title":"Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methods","volume":"19","author":"Gao","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1817669116","article-title":"DGAT1 inhibits retinol-dependent regulatory T cell formation and mediates autoimmune encephalomyelitis","volume":"116","author":"Graham","year":"2019","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.joen.2018.02.004","article-title":"Inhibition of SOX9 promotes inflammatory and immune responses of dental pulp","volume":"44","author":"Luo","year":"2018","journal-title":"J Endod"},{"key":"B22","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.celrep.2018.09.048","article-title":"Genetic architecture of adaptive immune system identifies key immune regulators","volume":"25","author":"Lagou","year":"2018","journal-title":"Cell Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"102608","DOI":"10.1016\/j.jaut.2021.102608","article-title":"Tissue-specific activation of Myd88-dependent pathways governs disease severity in primary sj\u00f6gren's syndrome","volume":"118","author":"Kiripolsky","year":"2021","journal-title":"J Autoimmun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.ymthe.2022.01.002","article-title":"METTL3-mediated m(6)A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy","volume":"30","author":"Jiang","year":"2022","journal-title":"Mol Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3120391","DOI":"10.1155\/2019\/3120391","article-title":"METTL3 attenuates LPS-induced inflammatory response in macrophages via NF-\u03baB signaling pathway","volume":"2019","author":"Wang","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2100209","DOI":"10.1002\/advs.202100209","article-title":"The m6A reader IGF2BP2 regulates macrophage phenotypic activation and inflammatory diseases by stabilizing TSC1 and PPAR\u03b3","volume":"8","author":"Wang","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear m(6)A reader YTHDC1 regulates mRNA splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.11.092","article-title":"S-adenosylmethionine synthesis is regulated by selective N(6)-adenosine methylation and mRNA degradation involving METTL16 and YTHDC1","volume":"21","author":"Shima","year":"2017","journal-title":"Cell Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature19342","article-title":"m(6)A RNA methylation promotes XIST-mediated transcriptional repression","volume":"537","author":"Patil","year":"2016","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.011","article-title":"HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events","volume":"162","author":"Alarc\u00f3n","year":"2015","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2019.01.013","article-title":"Clinical significance and immunobiology of IL-21 in autoimmunity","volume":"99","author":"Long","year":"2019","journal-title":"J Autoimmun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"110509","DOI":"10.1016\/j.biopha.2020.110509","article-title":"Emerging roles of non-coding RNAs in the pathogenesis of type 1 diabetes mellitus","volume":"129","author":"Taheri","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.09.015","article-title":"IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive b cells in humans","volume":"29","author":"Isnardi","year":"2008","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nature07336","article-title":"Innate immunity and intestinal microbiota in the development of type 1 diabetes","volume":"455","author":"Wen","year":"2008","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2016.08.001","article-title":"Imbalance between HDAC and HAT activities drives aberrant STAT1\/MyD88 expression in macrophages from type 1 diabetic mice","volume":"31","author":"Filgueiras","year":"2017","journal-title":"J Diabetes Complications"},{"key":"B36","doi-asserted-by":"publisher","first-page":"996\u20131000","DOI":"10.1111\/jpc.15884","article-title":"Toll-like receptor inflammatory cascade and the development of diabetic kidney disease in children and adolescents with type 1 diabetes","volume":"58","author":"de Melo","year":"2022","journal-title":"J Paediatr Child Health"},{"key":"B37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11892-019-1194-6","article-title":"Alterations in beta cell identity in type 1 and type 2 diabetes","volume":"19","author":"Moin","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e97732","DOI":"10.1172\/jci.insight.97732","article-title":"Virus-like infection induces human \u03b2 cell dedifferentiation","volume":"3","author":"Oshima","year":"2018","journal-title":"JCI Insight"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1524200113","article-title":"Growth factors and medium hyperglycemia induce Sox9+ ductal cell differentiation into \u03b2 cells in mice with reversal of diabetes","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2012389117","article-title":"Reversal of autoimmunity by mixed chimerism enables reactivation of \u03b2 cells and transdifferentiation of \u03b1 cells in diabetic NOD mice","volume":"117","author":"Tang","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B41","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1030728\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T13:50:28Z","timestamp":1668520228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1030728\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2022.1030728"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1030728","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"article-number":"1030728"}}